|
| Exchange Received Time 17/01/2018 14:59:35 Exchange Disseminated Time 17/01/2018 14:59:43 Time Taken 00:00:08 | Changes in the Board of Directors
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform about the following changes in the Board of Directors:
1.Resignation of Mr. Pramod Yadav: Consequent to his appointment as CEO Designate of Jubilant Pharma Limited, a wholly owned subsidiary of the Company, Mr Pramod Yadav has submitted his resignation as Director and Whole-time Director of the Company. The Board has, at its meeting held today i.e. January 17, 2018, accepted his resignation with immediate effect.
2.Appointment of Mr. Rajesh Srivastava as Whole-time Director: The Board has, at the said meeting, approved the appointment of Mr. Srivastava as an Additional Director and Whole-time Director of the Company with immediate effect. Brief profile of Mr. Srivastava is given as an Annexure to this letter. Mr. Srivastava is not related to any Director of the Company.
|
|
|